Company Description
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems.
The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.
This segment also offers consultation services to clients throughout their experimental design and implementation processes.
The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services.
The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations.
The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.
Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
| Country | United States |
| Founded | 1978 |
| IPO Date | Feb 1, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 3,300 |
| CEO | John P. Marotta |
Contact Details
Address: 200 Summit Drive, 6th Floor Burlington, Massachusetts 01803 United States | |
| Phone | 888 229 3682 |
| Website | azenta.com |
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| Employer ID | 04-3040660 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| Luc Provost | Vice President and Chief Executive Officer of B Medical Systems |
| John P. Marotta | President, Chief Executive Officer and Director |
| Dr. Ginger Zhou Ph.D. | Senior Vice President and President of GENEWIZ |
| Lawrence Y. Lin | Executive Vice President and Chief Financial Officer |
| Violetta Hughes | Vice President and Chief Accounting Officer |
| Michael Paulo | Vice President, Chief Information and Digital Officer |
| Yvonne Perron | Vice President of Financial Planning and Analysis and Investor Relations |
| Ephraim Starr | Senior Vice President, General Counsel and Corporate Secretary |
| Olga Pirogova | Senior Vice President and Chief Human Resources Officer |
| J. Robert Woodward | Senior Vice President of Global Quality and Engineering |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 2, 2025 | 8-K | Current Report |
| May 30, 2025 | SD | Form - SD |
| May 16, 2025 | 8-K | Current Report |
| May 9, 2025 | 10-Q | Quarterly Report |
| May 7, 2025 | 8-K | Current Report |
| Apr 29, 2025 | SCHEDULE 13G/A | Filing |
| Apr 9, 2025 | 8-K | Current Report |
| Feb 10, 2025 | 10-Q | Quarterly Report |
| Feb 5, 2025 | 8-K | Current Report |
| Jan 30, 2025 | 8-K | Current Report |